Envista (NVST) Scheduled to Post Earnings on Wednesday

Envista (NYSE:NVST) is set to release its earnings data before the market opens on Wednesday, October 30th. Analysts expect Envista to post earnings of $0.09 per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. The firm had revenue of $633.10 million during the quarter, compared to the consensus estimate of $646.88 million. During the same period in the previous year, the firm earned $0.43 EPS. The business’s revenue was down 4.4% compared to the same quarter last year. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Envista Trading Down 0.7 %

Shares of NVST opened at $18.89 on Monday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.90 and a current ratio of 2.22. Envista has a fifty-two week low of $15.15 and a fifty-two week high of $25.64. The company’s fifty day moving average is $18.48 and its 200 day moving average is $18.04. The stock has a market capitalization of $3.25 billion, a PE ratio of -26.24 and a beta of 1.32.

Insider Buying and Selling

In related news, CFO Eric D. Hammes acquired 24,532 shares of the firm’s stock in a transaction on Monday, August 12th. The shares were acquired at an average cost of $16.33 per share, with a total value of $400,607.56. Following the completion of the acquisition, the chief financial officer now directly owns 24,532 shares in the company, valued at approximately $400,607.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms have recently weighed in on NVST. Robert W. Baird cut their target price on Envista from $19.00 to $17.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Evercore ISI lifted their price objective on shares of Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. JPMorgan Chase & Co. lowered Envista from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $23.00 to $16.00 in a report on Thursday, August 8th. Stifel Nicolaus lifted their price target on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Piper Sandler lowered their price target on shares of Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a report on Tuesday, July 30th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Envista currently has a consensus rating of “Hold” and an average price target of $19.88.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.